Görgün Akpek

5.8k total citations
65 papers, 2.0k citations indexed

About

Görgün Akpek is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Görgün Akpek has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 19 papers in Oncology and 15 papers in Genetics. Recurrent topics in Görgün Akpek's work include Hematopoietic Stem Cell Transplantation (23 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Görgün Akpek is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Görgün Akpek collaborates with scholars based in United States, Canada and Türkiye. Görgün Akpek's co-authors include Georgia B. Vogelsang, Steven Piantadosi, Carl O’Hara, Daniel G. Wright, Viki Anders, Lewis R. Weintraub, Marianna Zahurak, David McAneny, Jeffrey Margolis and Emin Kansu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Görgün Akpek

61 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Görgün Akpek United States 25 1.1k 465 403 399 385 65 2.0k
Édouard Pertuiset France 22 828 0.8× 570 1.2× 614 1.5× 227 0.6× 225 0.6× 59 2.3k
Louis Letendre United States 25 1.1k 1.0× 563 1.2× 338 0.8× 490 1.2× 399 1.0× 76 2.1k
Nina Worel Austria 28 1.5k 1.3× 627 1.3× 267 0.7× 344 0.9× 534 1.4× 122 2.3k
Syuji Takei Japan 26 1.2k 1.1× 115 0.2× 424 1.1× 190 0.5× 750 1.9× 108 2.7k
José A. Gómez‐Puerta Spain 31 810 0.7× 163 0.4× 304 0.8× 199 0.5× 820 2.1× 154 3.3k
A. Heyll Germany 22 1.2k 1.1× 331 0.7× 412 1.0× 371 0.9× 196 0.5× 65 1.7k
Nathalie Fegueux France 27 1.8k 1.6× 632 1.4× 435 1.1× 267 0.7× 346 0.9× 88 2.3k
Milen Minkov Austria 31 1.0k 0.9× 567 1.2× 187 0.5× 197 0.5× 957 2.5× 85 3.7k
Peter Kalhs Austria 34 2.4k 2.2× 573 1.2× 325 0.8× 478 1.2× 1.1k 2.7× 119 3.3k
Barbara Degar United States 20 1.1k 1.0× 514 1.1× 425 1.1× 236 0.6× 696 1.8× 48 2.5k

Countries citing papers authored by Görgün Akpek

Since Specialization
Citations

This map shows the geographic impact of Görgün Akpek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Görgün Akpek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Görgün Akpek more than expected).

Fields of papers citing papers by Görgün Akpek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Görgün Akpek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Görgün Akpek. The network helps show where Görgün Akpek may publish in the future.

Co-authorship network of co-authors of Görgün Akpek

This figure shows the co-authorship network connecting the top 25 collaborators of Görgün Akpek. A scholar is included among the top collaborators of Görgün Akpek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Görgün Akpek. Görgün Akpek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Artz, Andrew, Brent R. Logan, Xiaochun Zhu, et al.. (2016). The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. Haematologica. 101(11). 1426–1433. 42 indexed citations
3.
Chen, Yi‐Bin, Andrew A. Lane, Brent R. Logan, et al.. (2015). Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(6). 1046–1053. 97 indexed citations
4.
Olsson, Richard F., Brent R. Logan, Sonali Chaudhury, et al.. (2015). Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 29(8). 1754–1762. 78 indexed citations
5.
Chen, Yi‐Bin, Andrew A. Lane, Brent R. Logan, et al.. (2014). Incidence and Risk Factors for the Development of Idiopathic Pneumonitis Syndrome (IPS) after Autologous Hematopoietic Cell Transplantation (AutoHCT) for Patients with Lymphoma. Biology of Blood and Marrow Transplantation. 20(2). S106–S106. 1 indexed citations
6.
7.
Akpek, Görgün, et al.. (2013). Frequent Detection of Herpes Simplex Virus Antigen in Skin and Peripheral Blood CD34+ Mononuclear Cells from Patients with Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 19(4). 529–537. 7 indexed citations
8.
Edelman, Bennett B., et al.. (2012). Plasma exchange and rituximab treatment for lenalidomide‐associated cold agglutinin disease. Transfusion. 52(11). 2432–2435. 16 indexed citations
9.
Akpek, Görgün, Marcelo C. Pasquini, Brent R. Logan, et al.. (2012). Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplantation. 48(6). 825–831. 52 indexed citations
10.
Akpek, Görgün. (2006). Titrating graft-versus-host disease: is it worth a try?. Bone Marrow Transplantation. 38(10). 653–656. 6 indexed citations
11.
Badros, Ashraf, Olga Goloubeva, Robert G. Fenton, et al.. (2006). Phase I Trial of First-Line Bortezomib/Thalidomide plus Chemotherapy for Induction and Stem Cell Mobilization in Patients with Multiple Myeloma. Clinical Lymphoma & Myeloma. 7(3). 210–216. 32 indexed citations
12.
Bolaños‐Meade, Javier, et al.. (2005). Lymphocytic pneumonitis as the manifestation of acute graft‐versus‐host disease of the lung. American Journal of Hematology. 79(2). 132–135. 9 indexed citations
13.
Lee, Stephanie J., Georgia B. Vogelsang, Andrew L. Gilman, et al.. (2002). A survey of diagnosis, management, and grading of chronic GVHD. Biology of Blood and Marrow Transplantation. 8(1). 32–39. 62 indexed citations
14.
Akpek, Görgün, Shing M. Lee, David Gagnon, Timothy P. Cooley, & Daniel G. Wright. (2001). Bone marrow aspiration, biopsy, and culture in the evaluation of HIV‐infected patients for invasive mycobacteria and histoplasma infections. American Journal of Hematology. 67(2). 100–106. 32 indexed citations
15.
Akpek, Görgün, Shing M. Lee, Viki Anders, & Georgia B. Vogelsang. (2001). A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation. 7(9). 495–502. 51 indexed citations
16.
Akpek, Görgün, et al.. (1999). Dihydropteridine Reductase Activity and Neopterin Levels in Leukemias and Lymphomas: Is There Any Correlation between These Two Parameters?. Leukemia & lymphoma. 35(3-4). 367–374. 12 indexed citations
17.
Koç, Yener, Görgün Akpek, Emin Kansu, et al.. (1998). Bolus and Continuous Infusion Mitoxantrone in Newly Diagnosed Adult Acute Lymphoblastic Leukemia: Results of Two Consecutive Phase II Clinical Studies: Original Articles. Cancer Investigation. 16(6). 355–365. 4 indexed citations
18.
Beneklı, Mustafa, Görgün Akpek, İbrahim Güllü, et al.. (1997). Small Intestinal Perforation in Hodgkin's Disease. Journal of Clinical Gastroenterology. 25(4). 699–701.
19.
Şahin, Gönül, et al.. (1995). Urinary Neopterin Levels as an Indicator of Disease Activation in Behçet’s Disease. Pteridines. 6(2). 79–83. 6 indexed citations
20.
Yalçın, Şuayib, Emin Kansu, İhsan Ertenli, et al.. (1995). 591 Granulocyte-colony stimulating factor (G-CSF) administration for chemotherapy-induced neutropenia. European Journal of Cancer. 31. S125–S125. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Édouard Pertuiset Breakdown of academic impact, for papers by Louis Letendre Breakdown of academic impact, for papers by Nina Worel Breakdown of academic impact, for papers by Syuji Takei Breakdown of academic impact, for papers by José A. Gómez‐Puerta Breakdown of academic impact, for papers by A. Heyll Breakdown of academic impact, for papers by Nathalie Fegueux Breakdown of academic impact, for papers by Milen Minkov Breakdown of academic impact, for papers by Peter Kalhs Breakdown of academic impact, for papers by Barbara Degar
Rankless by CCL
2026